The European Commission, on May 28, approved the use of the Covid-19 vaccine from Pfizer and its partner BioNTech for children 12 years of age and older, paving the way for the implementation of vaccinations for children of all ages. widely within the bloc, after similar decisions were made by the US and Canada.
Pfizer’s Covid-19 vaccine vial. Photo: Reuters. The European Commission, on May 28, approved the use of the Covid-19 vaccine from Pfizer and its partner BioNTech for children 12 years of age and older, paving the way for the implementation of vaccinations for children of all ages. widely within the bloc, after similar decisions were made by the US and Canada. The decision came after the European Medicines Agency (EMA) advocated the use of the vaccine in children aged 12 to 15 years earlier. This vaccine has been used in the European Union for people 16 years of age and older. For the 12-15 age group, the two doses of the vaccine are also given at least three weeks apart, as with adults, the EMA said. According to the EMA, each EU country will decide whether and when to provide the vaccine to adolescents. While awaiting the decision of the EMA, on May 27, Germany outlined a plan to provide vaccines for children from 12 years old from June 7. Italy also said that it is preparing to expand its Covid-19 vaccination campaign to people over 12 years old. Immunizing children and adolescents is seen as an important step towards achieving “herd immunity” and taming the pandemic. On May 28, Japan also joined other countries that decided to give the Pfizer vaccine to children as young as 12 years old. Since March, Pfizer and Biontech have released trial data showing that their Covid-19 vaccine is 100% effective in protecting against infectious disease in a trial of 2,260 adolescents aged 12 to 15 years. .
You must log in to post a comment.